Literature DB >> 9373251

Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist.

D J Curtis1, D J Hilton, B Roberts, L Murray, N Nicola, C G Begley.   

Abstract

We have expressed a soluble N-glycosylated form of the murine interleukin-11 (IL-11) receptor alpha-chain (sIL-11R) and examined signaling in cells expressing the gp130 molecule. In the presence of gp130 but not the transmembrane IL-11R, the sIL-11R mediated IL-11-dependent differentiation of M1 leukemic cells and proliferation in Ba/F3 cells. Early intracellular events stimulated by the sIL-11R including phosphorylation of gp130, STAT 3, and SHP-2 were similar to signaling through the transmembrane IL-11R. IL-11 bound to sIL-11R with low affinity (kd 10 to 50 nmol/L). Binding of sIL-11R to gp130 was IL-11 dependent with intermediate affinity (kd 1.5 to 3.0 nmol/L). However, the concentration of IL-11 required for signaling through the sIL-11R was 10- to 20-fold greater than that required for cells expressing the transmembrane IL-11R and gp130 in the absence of sIL-11R. Furthermore, the sIL-11R was capable of antagonizing the activity of IL-11 when tested on cells expressing the transmembrane IL-11R and gp130. We propose that the observed IL-11 antagonism by the sIL-11R may depend on limiting numbers of gp130 molecules on cells already expressing the transmembrane IL-11R.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373251

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat.

Authors:  Alicia Requena Jimenez; Naila Naz; Jaleel A Miyan
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-25       Impact factor: 6.200

2.  IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.

Authors:  Hatem A Elshabrawy; Michael V Volin; Abdul B Essani; Zhenlong Chen; Iain B McInnes; Katrien Van Raemdonck; Karol Palasiewicz; Shiva Arami; Mark Gonzalez; Hossam M Ashour; Seung-Jae Kim; Guofei Zhou; David A Fox; Shiva Shahrara
Journal:  Angiogenesis       Date:  2018-01-11       Impact factor: 9.596

3.  Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells.

Authors:  J Audet; C L Miller; S Rose-John; J M Piret; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

5.  Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors.

Authors:  Kazuyuki Yamazumi; Toshiyuki Nakayama; Takafumi Kusaba; Chun Yang Wen; Ayumi Yoshizaki; Yuichi Yakata; Takeshi Nagayasu; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

6.  Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.

Authors:  M Mandel; M Gurevich; R Pauzner; N Kaminski; A Achiron
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 7.  Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor.

Authors:  Cate Moriasi; Dharmalingam Subramaniam; Shanjana Awasthi; Satish Ramalingam; Shrikant Anant
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

8.  A designer hyper interleukin 11 (H11) is a biologically active cytokine.

Authors:  Hanna Dams-Kozlowska; Katarzyna Gryska; Eliza Kwiatkowska-Borowczyk; Dariusz Izycki; Stefan Rose-John; Andrzej Mackiewicz
Journal:  BMC Biotechnol       Date:  2012-03-21       Impact factor: 2.563

9.  The dynamics of signal triggering in a gp130-receptor complex.

Authors:  Rishi Matadeen; Wai-Ching Hon; John K Heath; E Yvonne Jones; Stephen Fuller
Journal:  Structure       Date:  2007-04       Impact factor: 5.006

Review 10.  Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation.

Authors:  Juliane Lokau; Maria Agthe; Christoph Garbers
Journal:  Mediators Inflamm       Date:  2016-07-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.